Wave Life Sciences (WVE) Debt Ratio (2016 - 2018)

Wave Life Sciences (WVE) posted Debt Ratio of 0.03 for Q4 2018, up 23.24% on a QoQ basis from 0.03 in Q3 2018, and up 83.64% year-over-year from 0.02 in Q4 2017.

Wave Life Sciences (WVE) Debt Ratio (2016 - 2018) Analysis & Trends

Wave Life Sciences' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.03 for Q4 2018.

  • Quarterly Debt Ratio rose 83.64% year-over-year to 0.03 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 0.03 (up 83.64% YoY) and the FY2018 annual result came in at 0.03, up 83.64% from the prior year.
  • Debt Ratio was 0.03 for Q4 2018 at Wave Life Sciences, up from 0.03 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.03 in Q4 2018 and bottomed at 0.0 in Q4 2016.
  • A 3-year average of 0.02 and a median of 0.02 in 2017 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2017 — Debt Ratio jumped 2317.42% — and 2018, when it surged 83.64%.
  • Wave Life Sciences' Debt Ratio stood at 0.0 in 2016, then soared by 2317.42% to 0.02 in 2017, then jumped by 83.64% to 0.03 in 2018.
  • Business Quant data shows WVE's Debt Ratio at 0.03 in Q4 2018, 0.03 in Q3 2018, and 0.02 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Wave Life Sciences 1.16 Bn 612.38 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 0.03
Sep 30, 2018 0.03
Jun 30, 2018 0.02
Mar 31, 2018 0.03
Dec 31, 2017 0.02
Sep 30, 2017 0.01
Jun 30, 2017 0.01
Mar 31, 2017 0.01
Dec 31, 2016 0.00